Patents by Inventor Julien Marin

Julien Marin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds and method for treatment of HIV
    Patent number: 9624220
    Abstract: The invention relates to a compound of Formulae I and/or II: and/or a pharmaceutically-acceptable salt, hydrate, solvate, tautomer, optical isomer, E-isomer, Z-isomer, or combination thereof; X is selected from Se, N—OH, NH, NO2, CN, N—CN, N?O, O or S, and the remaining substituents are described herein; and a composition thereof. The invention also relates to a method of administration thereof; and use thereof to treat HIV.
    Type: Grant
    Filed: July 13, 2016
    Date of Patent: April 18, 2017
    Assignee: Critical Outcome Technologies Inc.
    Inventors: Wayne Danter, Clinton Threlfall, Sylvain Guizzetti, Julien Marin
  • COMPOUNDS AND METHOD FOR TREATMENT OF HIV
    Publication number: 20160333010
    Abstract: The invention relates to a compound of Formulae I and/or II: and/or a pharmaceutically-acceptable salt, hydrate, solvate, tautomer, optical isomer, E-isomer, Z-isomer, or combination thereof; X is selected from Se, N—OH, NH, NO2, CN, N—CN, N?O, O or S, and the remaining substituents are described herein; and a composition thereof. The invention also relates to a method of administration thereof; and use thereof to treat HIV.
    Type: Application
    Filed: July 13, 2016
    Publication date: November 17, 2016
    Inventors: Wayne Danter, Clinton Threlfall, Sylvain Guizzetti, Julien Marin
  • Compounds and method for treatment of HIV
    Patent number: 9422282
    Abstract: The invention relates to a compound of Formulae I and/or II: and/or a pharmaceutically-acceptable salt, hydrate, solvate, tautomer, optical isomer, E-isomer, Z-isomer, or combination thereof; X is selected from Se, N—OH, NH, NO2, CN, N—CN, N?O, O or S, and the remaining substituents are described herein; and a composition thereof. The invention also relates to a method of administration thereof; and use thereof to treat HIV.
    Type: Grant
    Filed: February 10, 2015
    Date of Patent: August 23, 2016
    Assignee: Critical Outcome Technologies Inc.
    Inventors: Wayne Danter, Clinton Threlfall, Sylvain Guizzetti, Julien Marin
  • COMPOUNDS AND METHOD FOR TREATMENT OF HIV
    Publication number: 20150183782
    Abstract: The invention relates to a compound of Formulae I and/or II: and/or a pharmaceutically-acceptable salt, hydrate, solvate, tautomer, optical isomer, E-isomer, Z-isomer, or combination thereof; X is selected from Se, N—OH, NH, NO2, CN, N—CN, N?O, O or S, and the remaining substituents are described herein; and a composition thereof. The invention also relates to a method of administration thereof; and use thereof to treat HIV.
    Type: Application
    Filed: February 10, 2015
    Publication date: July 2, 2015
    Inventors: Wayne Danter, Clinton Threlfall, Sylvain Guizzetti, Julien Marin
  • Compounds and method for treatment of HIV
    Patent number: 8987272
    Abstract: The invention relates to a compound of Formulae I and/or II: and/or a pharmaceutically-acceptable salt, hydrate, solvate, tautomer, optical isomer, E-isomer, Z-isomer, or combination thereof; X is selected from Se, N—OH, NH, NO2, CN, N—CN, N?O, O or S, and the remaining substituents are described herein; and a composition thereof. The invention also relates to a method of administration thereof; and use thereof to treat HIV.
    Type: Grant
    Filed: April 1, 2011
    Date of Patent: March 24, 2015
    Assignee: Critical Outcome Technologies Inc.
    Inventors: Wayne Danter, Clinton Threlfall, Sylvain Guizzetti, Julien Marin
  • COMPOUNDS AND METHOD FOR TREATMENT OF HIV
    Publication number: 20130217693
    Abstract: The invention relates to a compound of Formulae I and/or II: and/or a pharmaceutically-acceptable salt, hydrate, solvate, tautomer, optical isomer, E-isomer, Z-isomer, or combination thereof; X is selected from Se, N—OH, NH, NO2, CN, N—CN, N?O, O or S, and the remaining substituents are described herein; and a composition thereof. The invention also relates to a method of administration thereof; and use thereof to treat HIV.
    Type: Application
    Filed: April 1, 2011
    Publication date: August 22, 2013
    Inventors: Wayne Danter, Clinton Threlfall, Sylvain Guizzetti, Julien Marin